Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Daily Briefing: A bad flu season gets worse - 2Figure out How to Augment Eco-friendliness in Your Volvo XC40
- 3Russia earning billions from Hormuz blockade, German trade body says
- 4An Artemis 2 astronaut took a 'bath' on camera on the way to the moon. Mission Control's reaction was priceless (video)
- 5Saudi Arabia says it intercepted 7 missiles, debris falls near energy facilities
- How to Build a Yard That Helps Monarchs During Spring Migration
- A Colombian city swaps iconic horse buggies for electric carriages amid animal welfare concerns
- Texas cities have some of the highest preterm birth rates in the US, highlighting maternal health crisis nationwide
- Winter storm warnings issued across Northeast as up to 9 inches of snow forecast; deadly atmospheric river in California snarls travel
- Where You Could Sleep With Snorlax in Japan, From MIMARU’s Pokémon Rooms to Grand Hyatt Tokyo’s Limited Pokémon Suite
- Big majority in Germany call Berlin's efforts on gas prices too weak
- More than 3 million eye drops have been recalled from CVS, Walgreens and other national retailers. How to check if yours are safe
- The Latest: Fueling begins as NASA aims to send 1st crew to the moon in 53 years
- Best Veggie lover Dinner: What's Your Plant-Based Pick?
